Using a simplified human immunodeficiency virus type 1 p24 antigen assay to diagnose pediatric HIV-infection in Malawi

Journal of Clinical Virology

Volumn 49, Issue 4, 2010, Pages 299-302

  Mwapasa, Victor ^a   Cachafeiro, Ada ^b   Makuta, Yohane ^a   Beckstead, David J ^c   Pennell, Michael L ^d   Chilima, Ben ^e   Mwagomba, Beatrice ^f   Fiscus, Susan A ^b   Kwiek, Jesse J ^d,g  

^a UNIVERSITY OF MALAWI   (Malawi)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e MINISTRY OF HEALTH   (Malawi)

^f Thyolo District Hospital   (Malawi)

^g NONE   (United States)

Author keywords

Diagnostics; Dried blood spot (DBS); HIV 1 p24 antigen detection assay; Human immunodeficiency virus type 1 (HIV 1); Malawi; Pediatrics

Indexed keywords

ANTIGEN P24; VIRUS DNA;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; MALAWI; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

BLOOD; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALAWI; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VIROLOGY;

EID: 78149501131     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.08.013     Document Type: Article

References (25)

1. Violari A., Cotton M.F., Gibb D.M., Babiker A.G., Steyn J., Madhi S.A., et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008, 359(21):2233-2244.
2. World Health Organization, UNAIDS UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector, 2010. http://www.who.int/hiv/pub/tuapr_2009_en.pdf.
3. National AIDS Commission. Malawi HIV and AIDS monitoring and evaluation report: 2008-2009. Lilongwe: UNGASS Country Progress Report, 2010.
4. ITAD. Final report of the independent review of Malawi national response of HIV and AIDS for fiscal year 2008-2009. Lilongwe: ITAD, 2009.
5. National Statistics Office. 2008 Malawi population and housing census (accessed from on 10th July 2010). http://www.nso.malawi.net/.
6. Fiscus S.A., Wiener J., Abrams E.J., Bulterys M., Cachafeiro A., Respess R.A. Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection. J Clin Microbiol 2007, 45(7):2274-2277.
7. Lyamuya E., Bredberg-Raden U., Massawe A., Urassa E., Kawo G., Msemo G., et al. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12(4):421-426.
8. Nadal D., Boni J., Kind C., Varnier O.E., Steiner F., Tomasik Z., et al. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis 1999, 180(4):1089-1095.
9. Nouhin J., Nguyen M. Evaluation of a boosted-p24 antigen assay for the early diagnosis of pediatric HIV-1 infection in Cambodia. Am J Trop Med Hyg 2006, 75(6):1103-1105.
10. Schupbach J., Boni J., Tomasik Z., Jendis J., Seger R., Kind C. Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis 1994, 170(2):318-324.
11. Sherman G.G., Stevens G., Stevens W.S. Affordable diagnosis of human immunodeficiency virus infection in infants by p24 antigen detection. Pediatr Infect Dis J 2004, 23(2):173-176.
12. Zijenah L.S., Tobaiwa O., Rusakaniko S., Nathoo K.J., Nhembe M., Matibe P., et al. Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years. J Acquir Immune Defic Syndr 2005, 39(4):391-394.
13. Cachafeiro A., Sherman G.G., Sohn A.H., Beck-Sague C., Fiscus S.A. Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay. J Clin Microbiol 2009, 47(2):459-462.
14. Knuchel M.C., Jullu B., Shah C., Tomasik Z., Stoeckle M.P., Speck R.F., et al. Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing. J Acquir Immune Defic Syndr 2007, 44(3):247-253.
15. Patton J.C., Coovadia A.H., Meyers T.M., Sherman G.G. Evaluation of the ultrasensitive human immunodeficiency virus (HIV)-1 p24 antigen assay on dried blood spots (DBS) for infant diagnosis. Clin Vaccine Immunol 2007, 15(2):388-391.
16. Patton J.C., Sherman G.G., Coovadia A.H., Stevens W.S., Meyers T.M. Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood spots as a reliable, affordable test for infant diagnosis. Clin Vaccine Immunol 2006, 13(1):152-155.
17. Burgisser P., Vernazza P., Flepp M., Boni J., Tomasik Z., Hummel U., et al. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2000, 23(2):138-144.
18. Goldschmidt P.L., Devillechabrolle A., Ait-Arkoub Z., Aubin J.T. Comparison of an amplified enzyme-linked immunosorbent assay with procedures based on molecular biology for assessing human immunodeficiency virus type 1 viral load. Clin Diagn Lab Immunol 1998, 5(4):513-518.
19. Patton J.C., Akkers E., Coovadia A.H., Meyers T.M., Stevens W.S., Sherman G.G. Evaluation of dried whole blood spots obtained by heel or finger stick as an alternative to venous blood for diagnosis of human immunodeficiency virus type 1 infection in vertically exposed infants in the routine diagnostic laboratory. Clin Vaccine Immunol 2007, 14(2):201-203.
20. George E., Beauharnais C.A., Brignoli E., Noel F., Bois G., De Matteis Rouzier P., et al. Potential of a simplified p24 assay for the early diagnosis of infant HIV-1 infection in Haiti. J Clin Microbiol 2007, 45(10):3416-3418.
21. Simel D.L., Samsa G.P., Matchar D.B. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991, 44(8):763-770.
22. Biggar R.J., Miotti P.G., Taha T.E., Mtimavalye L., Broadhead R., Justesen A., et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996, 347(9016):1647-1650.
23. Semba R.D., Kumwenda N., Hoover D.R., Taha T.E., Quinn T.C., Mtimavalye L., et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999, 180(1):93-98.
24. Taha T.E., Kumwenda N.I., Gibbons A., Broadhead R.L., Fiscus S., Lema V., et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet 2003, 362(9391):1171-1177.
25. Taha T.E., Kumwenda N.I., Hoover D.R., Fiscus S.A., Kafulafula G., Nkhoma C., et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA 2004, 292(2):202-209.